Get the Stockscreener App
3.69
3.15%
-0.12
After Hours:
3.54
-0.15
-4.07%
Engene Holdings Inc stock is traded at $3.69, with a volume of 26,923.
It is down -3.15% in the last 24 hours and up +23.41% over the past month.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
See More
Previous Close:
$3.81
Open:
$3.825
24h Volume:
26,923
Relative Volume:
0.34
Market Cap:
$188.58M
Revenue:
-
Net Income/Loss:
$-103.21M
P/E Ratio:
-0.8022
EPS:
-4.6001
Net Cash Flow:
$-26.70M
1W Performance:
+0.27%
1M Performance:
+23.41%
6M Performance:
-48.46%
1Y Performance:
-57.34%
1-Day Range:
$3.6201
$3.94
1-Week Range:
$3.6201
$4.00
52-Week Range:
$2.65
$11.00
Engene Holdings Inc Stock (ENGN) Company Profile
Name
Engene Holdings Inc
Sector
Industry
Phone
(514) 332-4888
Address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Compare ENGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
3.69 | 197.27M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-25 | Initiated | Piper Sandler | Overweight |
| Feb-14-25 | Downgrade | UBS | Buy → Neutral |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| Nov-27-24 | Initiated | Raymond James | Outperform |
| Nov-18-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-28-24 | Initiated | Oppenheimer | Outperform |
| Apr-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-15-24 | Initiated | Guggenheim | Buy |
| Mar-28-24 | Initiated | UBS | Buy |
| Mar-08-24 | Initiated | Morgan Stanley | Overweight |
| Feb-20-24 | Initiated | Leerink Partners | Outperform |
View All
Engene Holdings Inc Stock (ENGN) Latest News
What analysts say about enGene Holdings Inc. stockSuperior risk-adjusted returns - PrintWeekIndia
What analysts say about enGene Holdings Inc. Equity Warrant stockSuperior capital gains - jammulinksnews.com
What drives enGene Holdings Inc. stock priceUnstoppable trading performance - Autocar Professional
Is enGene Holdings Inc. Equity Warrant a good long term investmentTriple-digit return opportunities - Autocar Professional
Is enGene Holdings Inc. a good long term investmentFree Trend-Following Techniques - jammulinksnews.com
What drives enGene Holdings Inc. Equity Warrant stock pricePhenomenal capital gains - jammulinksnews.com
enGene Holdings Inc. Stock Analysis and ForecastTremendous wealth creation - jammulinksnews.com
Why enGene Holdings Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser
enGene Holdings Inc. Equity Warrant Stock Analysis and ForecastSkyrocketing returns - Autocar Professional
When (ENGN) Moves Investors should Listen - news.stocktradersdaily.com
Why enGene Holdings Inc. Equity Warrant stock attracts strong analyst attentionFree Risk Assessment Services - Newser
What makes enGene Holdings Inc. stock price move sharplyFree Access to Community - Newser
How enGene Holdings Inc. Equity Warrant stock performs during market volatilityHigh Yield Opportunities - Newser
What makes enGene Holdings Inc. Equity Warrant stock price move sharplyMulti Bagger Alerts - Newser
Engene Holdings Inc Stock (ENGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.32%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):